Insiders · Profile

Krainer Adrian R.

Director at Stoke Therapeutics. Filing since 14 Nov 2025. CIK 0001780081

Company
Date
Role
Action
Shares
Amount
Of holding
10 Mar 2026
Director
Sold on a plan
33,243
$1.32M
10.5%
2 Mar 2026
Director
Sold on a plan
7,229
$286.72K
2.2%
24 Nov 2025
Director
Sold on a plan
40,472
$1.20M
11.1%
14 Nov 2025
Director
Sold on a plan
40,472
$1.09M
10.0%
4 decisions on file.